Avita Medical Inc. (RCEL) Balance Sheet

Assets have fallen every quarter but one since 2024Q1, from $97.4M to $47.8M, while liabilities expanded from $64.8M to $75.6M, so the $60.4M equity swing is being driven on both sides rather than by a single write-down. The pattern is consistent with a business funding persistent losses by drawing down current assets and adding liabilities, which implies the narrowing operating loss seen on the income statement has not yet translated into balance sheet repair. Investors should monitor whether the trajectory inflects before assets fall below the liability stack entirely.

Debt has risen steadily from $44.7M to $48.5M even as equity turned negative, so leverage has shifted from strategic to necessity-driven in character; the D/E ratio is undefined precisely because the equity cushion has vanished. With debt equal to roughly 5.3x the cash balance and slightly more than total assets, coverage appears to rest entirely on forward operating cash generation rather than on the balance sheet itself. The maturity profile is not disclosed in the supplied data, but the direction of travel suggests refinancing risk warrants close attention.

A sub-0.5x current ratio alongside $9.1M of cash implies current liabilities materially exceed current assets, a configuration that typically forces either liability deferral, asset sales or external capital raises. The decline has been relentless rather than episodic — 7.25, 5.29, 3.73, 2.83, 2.09, then sub-1.0 for four straight quarters — which suggests a structural working capital squeeze rather than seasonal noise. Read against the improving free cash flow trend in prior analysis, the liquidity buffer appears to be narrowing faster than burn is easing.

The $110.1M deterioration in retained earnings over ten quarters closely tracks the cumulative net losses previously identified, confirming that operating performance — not capital return activity — is the sole architect of the negative equity position. Equity crossed zero between 2025Q2 and 2025Q3 and has deepened each quarter since, which historically correlates with higher borrowing costs and stricter covenant scrutiny for issuers in this tier. Because book equity is negative, conventional valuation multiples anchored to book value become uninformative, shifting analytical weight onto revenue durability and cash burn.